Article ; Online: In vitro
2023 Volume 29, Issue 11, Page(s) 883–891
Abstract: Introduction: Quercetin (3,3',4',5,7-pentahydroxyflavone) is a dietary flavonoid with good antioxidant and anti-inflammatory properties.: Aims: The present study aims to determine these effects in peripheral blood mononuclear cells (PBMCs) evoked by ... ...
Abstract | Introduction: Quercetin (3,3',4',5,7-pentahydroxyflavone) is a dietary flavonoid with good antioxidant and anti-inflammatory properties. Aims: The present study aims to determine these effects in peripheral blood mononuclear cells (PBMCs) evoked by lipopolysaccharides (LPS). Methods: The mRNA expression and protein secretion of inflammatory mediators were evaluated by enzyme- linked immunosorbent assay (ELISA) and quantitative real-time polymerase chain reaction (PCR), respectively. Western blotting was utilized for assessing p65-NF-κB phosphorylation. Ransod kits evaluated the glutathione peroxidase (GPx) and superoxide dismutase (SOD) activity in the cell lysates. Ultimately, the molecular docking approach was performed to investigate the biological activity of Quercetin against NF-κB pathway proteins and antioxidant enzymes. Results: The findings revealed that quercetin significantly attenuated the expression and secretion of inflammatory mediators and p65-NF-κB phosphorylation in LPS-induced PBMCs. Additionally, quercetin dose-dependently improved the activities of SOD and GPx enzymes and decreased LPS-mediated oxidative stress in PBMCs. Moreover, quercetin has a considerable binding affinity to IκKb, the core element of the NF-κB pathway and the antioxidant enzyme SOD. Conclusion: The data show that quercetin plays a vital role in ameliorating inflammation and oxidative stress caused by LPS in PBMCs. |
---|---|
MeSH term(s) | Humans ; Antioxidants/pharmacology ; Antioxidants/therapeutic use ; Quercetin/pharmacology ; Quercetin/therapeutic use ; NF-kappa B/metabolism ; Molecular Docking Simulation ; Lipopolysaccharides/pharmacology ; Leukocytes, Mononuclear/metabolism ; Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/therapeutic use ; Inflammation/drug therapy ; Inflammation/metabolism ; Superoxide Dismutase/metabolism ; Superoxide Dismutase/therapeutic use ; Inflammation Mediators/therapeutic use |
Chemical Substances | Antioxidants ; Quercetin (9IKM0I5T1E) ; NF-kappa B ; Lipopolysaccharides ; Anti-Inflammatory Agents ; Superoxide Dismutase (EC 1.15.1.1) ; Inflammation Mediators |
Language | English |
Publishing date | 2023-04-02 |
Publishing country | United Arab Emirates |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 1304236-1 |
ISSN | 1873-4286 ; 1381-6128 |
ISSN (online) | 1873-4286 |
ISSN | 1381-6128 |
DOI | 10.2174/1381612829666230330084043 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 4714: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.